文献速递青光眼

基于趋势分析的光学相干断层扫描测量黄斑区神经节细胞-内丛状层厚度变化在青光眼进展中的评估

Trend-based Analysis of Ganglion Cell-Inner Plexiform Layer Thickness Changes on Optical Coherence Tomography in Glaucoma Progression.
PubMed 文献 · Ophthalmology · 2017-04-12

这项前瞻性观察研究纳入65例原发性开角型青光眼患者,随访至少3年并连续行频域OCT测量黄斑区神经节细胞-内丛状层(GCIPL)厚度。根据系列无赤光眼底照相或视野检查将患者分为进展组(27例)和非进展组(38例),比较两组GCIPL变薄速率。结果显示进展组整体、受累半侧视野及多个黄斑分区GCIPL变薄速率均显著快于非进展组,基于趋势分析的GCIPL变薄速率可能有助于客观定量评估青光眼进展。

要点

  • 进展组整体GCIPL变薄速率显著快于非进展组(P < 0.001)。
  • 进展组受累半侧视野GCIPL变薄速率显著快于非进展组(P = 0.001)。
  • 整体GCIPL变薄速率诊断青光眼进展的AUC为0.791,为最佳参数。

核心结论

  • 进展组青光眼患者OCT测量的GCIPL变薄速率显著快于非进展组。
  • 颞侧分区GCIPL变薄速率在受累半侧视野快于未受累半侧视野,提示青光眼损害可能按特定顺序局部进展。
  • 基于趋势分析的OCT GCIPL厚度测量可能有助于客观定量评估青光眼进展。

研究设计与样本

  • 前瞻性观察性研究,纳入65例原发性开角型青光眼患者,随访至少3年,连续行频域OCT测量GCIPL厚度。
  • 根据系列无赤光眼底照相或视野检查将患者分为非进展组(38例)和进展组(27例)。
  • 通过线性回归测定整体、受累半侧视野、6个黄斑分区及最小GCIPL厚度的变薄速率,并计算各参数的受试者工作特征曲线下面积(AUC)。

主要发现

  • 进展组较非进展组GCIPL变薄速率在整体区域显著更快(P < 0.001)。
  • 进展组较非进展组GCIPL变薄速率在受累半侧视野显著更快(P = 0.001)。
  • 进展组较非进展组GCIPL变薄速率在受累半侧视野的颞侧、垂直和鼻侧分区显著更快(P = 0.017、0.032和0.030)。
  • 进展组较非进展组最小GCIPL厚度变薄速率显著更快(P < 0.001)。
  • 颞侧分区GCIPL变薄速率在受累半侧视野显著快于未受累半侧视野(P = 0.013)。

关键数值与推荐

  • GCIPL变薄速率诊断青光眼进展的AUC:整体0.791、最小厚度0.755、下半侧视野0.708、受累半侧视野0.702。
  • 整体环视乳头视网膜神经纤维层变薄速率与整体及颞下分区GCIPL变薄速率显著相关(rho = 0.259和0.366)。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate the rate of thinning in ganglion cell-inner plexiform layer (GCIPL) thickness by optical coherence tomography (OCT) in glaucomatous eyes and to use a trend-based approach to determine its diagnostic ability for detecting glaucoma progression. DESIGN: Prospective, observational study. PARTICIPANTS: Sixty-five patients with primary open-angle glaucoma with a minimum 3-year follow-up involving serial spectral-domain OCT measurement of GCIPL thickness. METHODS: Patients were divided into a nonprogressor group (n = 38) and a progressor group (n = 27) on the basis of serial red-free photography or visual field tests. The rates of GCIPL thinning in the global region, affected hemifield, and 6 macular sectors, and the minimum thickness, were determined by linear regression and compared between groups. The area under the receiver operating characteristic curves (AUCs) were calculated for each parameter. The GCIPL thinning rates were compared between affected hemifields and unaffected hemifields. MAIN OUTCOME MEASURES: The macular GCIPL thinning rates in the progressor and nonprogressor groups and the ability of the GCIPL thinning rate to diagnose glaucoma progression. RESULTS: The GCIPL thinning rate was significantly faster in progressors than in nonprogressors in the global area (P < 0.001); in the affected hemifield (P = 0.001); in the temporal, vertical, and nasal sectors of the affected hemifield (P = 0.017, 0.032, and 0.030, respectively); and in the minimum GCIPL thickness (P < 0.001). In the temporal sectors, the GCIPL thinning rates were significantly faster in the affected than in the unaffected hemifield (P = 0.013). The best GCIPL parameters were the global (AUC = 0.791), minimum (AUC = 0.755), inferior hemifield (AUC = 0.708), and affected hemifield (AUC = 0.702) thinning rates. The global circumpapillary retinal nerve fiber layer thinning rate correlated significantly with the global and inferotemporal sector GCIPL thinning rates (rho = 0.259 and 0.366, respectively). CONCLUSIONS: The GCIPL thinning rate on OCT was significantly faster for patients with glaucoma with progression than for those without progression. The GCIPL thinning rate of the temporal sector was faster in the affected than in the unaffected hemifield, suggesting that the glaucomatous damage may progress locally in a specific sequence. Trend-based analysis of GCIPL thickness on OCT may be useful for assessing glaucoma progression objectively and quantitatively.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Lee WJ, Kim YK, Park KH, et al. Trend-based Analysis of Ganglion Cell-Inner Plexiform Layer Thickness Changes on Optical Coherence Tomography in Glaucoma Progression. Ophthalmology. 2017. PMID: 28412067. doi:10.1016/j.ophtha.2017.03.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。